✦ LIBER ✦
PND13 A COST-EFFECTIVENESS ANALYSIS OF NATALIZUMAB VS. INTERFERON-BETA AND GLATIRAMER ACETATE IN PATIENTS WITH ACTIVE RELAPSING-REMITTING MULTIPLE SCLEROSIS CURRENTLY FAILING ON EXISTING THERAPY
✍ Scribed by R Gani; ER Samuels; S Hughes; G Giovanonni
- Book ID
- 118609140
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 72 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.